Elite in Trichomoniasis

Dr. Jane Schwebke

Internal Medicine
University Of Alabama Hospital
619 19th St S, 
Birmingham, AL 
Elite in Trichomoniasis
University Of Alabama Hospital
619 19th St S, 
Birmingham, AL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Jane Schwebke is an Internal Medicine provider in Birmingham, Alabama. Dr. Schwebke is rated as an Elite provider by MediFind in the treatment of Trichomoniasis. Her top areas of expertise are Trichomoniasis, Vaginal Yeast Infection, Urethritis, and Chlamydia.

Her clinical research consists of co-authoring 112 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 35 articles and participated in 2 clinical trials in the study of Trichomoniasis.

Specialties
Internal Medicine
Licenses
Internal Medicine in AL
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
VIVA Health
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL

Locations

University of Alabama Hospital
619 19th St S, Birmingham, AL 35233

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oteseconazole (VT-1161) Oral Capsules in the Treatment of Subjects With Recurrent Vulvovaginal Candidiasis
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oteseconazole (VT-1161) Oral Capsules in the Treatment of Subjects With Recurrent Vulvovaginal Candidiasis
Enrollment Status: Completed
Publish Date: April 06, 2022
Intervention Type: Drug
Study Drug: VT-1161
Study Phase: Phase 3
A Phase 2, Multicenter, Randomized, Double-Blind, Double-Dummy, Active-Controlled, Dose-Finding Study to Compare the Safety and Efficacy of Oral Ibrexafungerp (SCY-078) vs. Oral Fluconazole in Subjects With Acute Vulvovaginal Candidiasis
A Phase 2, Multicenter, Randomized, Double-Blind, Double-Dummy, Active-Controlled, Dose-Finding Study to Compare the Safety and Efficacy of Oral Ibrexafungerp (SCY-078) vs. Oral Fluconazole in Subjects With Acute Vulvovaginal Candidiasis
Enrollment Status: Completed
Publish Date: August 12, 2021
Intervention Type: Drug
Study Phase: Phase 2
Solubilized Metronidazole And/oR Terconazole Gels Intra-Vaginal Efficacy and Safety
Solubilized Metronidazole And/oR Terconazole Gels Intra-Vaginal Efficacy and Safety
Enrollment Status: Completed
Publish Date: August 04, 2020
Intervention Type: Drug
Study Phase: Phase 3
Solubilized Metronidazole And/oR Terconazole Gels Intra-Vaginal Efficacy and Safety
Solubilized Metronidazole And/oR Terconazole Gels Intra-Vaginal Efficacy and Safety
Enrollment Status: Completed
Publish Date: July 27, 2020
Intervention Type: Drug
Study Phase: Phase 3
Randomized Controlled Trial of Treatment of Male Partners of Women With BV
Randomized Controlled Trial of Treatment of Male Partners of Women With BV
Enrollment Status: Completed
Publish Date: April 27, 2020
Intervention Type: Other, Drug
Study Phase: Phase 3
Trichomonas Vaginalis Repeat Infections Among HIV Negative Women
Trichomonas Vaginalis Repeat Infections Among HIV Negative Women
Enrollment Status: Completed
Publish Date: February 12, 2019
Intervention Type: Drug
Study Phase: Phase 3
Solana™ Trichomonas Assay Field Study
Solana™ Trichomonas Assay Field Study
Enrollment Status: Completed
Publish Date: March 20, 2018
Intervention Type: Device
View 6 Less Clinical Trials

112 Total Publications

Vaginitis and risk of sexually transmitted infections: results of a multi-center U.S. clinical study using STI nucleic acid amplification testing.
Vaginitis and risk of sexually transmitted infections: results of a multi-center U.S. clinical study using STI nucleic acid amplification testing.
Journal: Journal of clinical microbiology
Published: August 14, 2024
Similar Doctors
Experienced in Trichomoniasis
Dr. Greer Burkholder
Internal Medicine
Experienced in Trichomoniasis
Dr. Greer Burkholder
Internal Medicine

Office

845 19th St S, 
Birmingham, AL 
 (0.4 miles away)
205-934-1917
Languages Spoken:
English
See accepted insurances

Greer Burkholder is an Internal Medicine provider in Birmingham, Alabama. Dr. Burkholder is rated as a Distinguished provider by MediFind in the treatment of Trichomoniasis. Her top areas of expertise are HIV/AIDS, Myelitis, AIDS Dysmorphic Syndrome, and AIDS Dementia Complex.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Schwebke's expertise for a condition
ConditionClose
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile